Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer

BACKGROUND: Our study aimed to evaluate the safety and immunogenicity of the third (booster) dose of the COVID-19 vaccine for patients with endocrine-related cancers. METHODS: This observational study involved 94 breast cancer patients, 92 thyroid cancer patients, and 123 healthy individuals who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Shanshan, Yang, Yuping, Wang, Tingrui, Song, Rui, Hu, Daixing, Peng, Mingli, Lin, Zijing, Deng, Qin, Ren, Hong, Ming, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932592/
https://www.ncbi.nlm.nih.gov/pubmed/36817926
http://dx.doi.org/10.3389/fpubh.2023.1086872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932592/
https://www.ncbi.nlm.nih.gov/pubmed/36817926
http://dx.doi.org/10.3389/fpubh.2023.1086872

Ejemplares similares